quadruplet therapies for treating mm: the current evidence and the findings of a phase ii trial
Published 6 months ago • 237 plays • Length 9:57Download video MP4
Download video MP3
Similar videos
-
1:13
second-line treatment strategies for patients with relapsed dlbcl
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
8:13
treatment strategies for high-risk mm
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:45
a phase ii study of elritercept for lower-risk mds
-
2:41
israeli company on the edge of finding diabetes cure
-
9:25
mgus diagnosis: a step-by-step approach
-
2:57
imetelstat for lr-mds: insights from the imerge trial
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:17
phase ii study of tosedostat in mds
-
2:40
the role of consolidation therapy in mm and updates from the emn02 trial
-
2:17
extended follow-up of the master trial
-
4:45
phase ib/ii multi-arm study of combinations of novel agents in r/r aml
-
1:33
sequencing and the management of adverse events when administering bispecifics for myeloma
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl